Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
Influence of Socioeconomic Status on Features and Outcome of Community-Acquired Pneumonia
Authors
S. Stelianides
J. L. Golmard
C. Carbon
B. Fantin
Publication date
01-11-1999
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/1999
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s100960050382

Other articles of this Issue 10/1999

European Journal of Clinical Microbiology & Infectious Diseases 10/1999 Go to the issue

Note

Cefotaxime-Hydrolysing Beta Lactamases in Morganella morganii

Article

Response to Interferon Alfa-2b Therapy in Multitransfused Children with Beta-thalassemia and Chronic Hepatitis C

Brief Reports

A Case of Oesophageal Leishmaniasis Indicating Visceral Leishmaniasis in a Patient with AIDS

Review

Vancomycin Resistance: Status Quo and Quo Vadis

Note

Usefulness of Immunochromatographic Detection of Antibodies to Mycobacterium tuberculosis as an Adjunct to Auramine Staining for Rapid Diagnosis of Tuberculosis in a Low-Prevalence Setting

Note

Semiquantitative Polymerase Chain Reaction Enzyme Immunoassay for the Diagnosis of Pertussis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits